Insulet | PODD - Trade Creditors


Insulet reported $162.2M in Trade Creditors for its fiscal quarter ending in September of 2026.





Trade Creditors Change Date
Abbott USD 4.68B 439M Mar/2026
Align Technology USD 117.88M 8.04M Sep/2026
AtriCure USD 80.24M 1.5M Sep/2026
Baxter International USD 1.02B 10M Sep/2026
Becton, Dickinson and Co. USD 6.11B 173M Jun/2026
Boston Scientific USD 1.25B 19M Sep/2026
Cardinal Health USD 40.94B 2.65B Sep/2026
Cooper Companies USD 251.2M 17.9M Jun/2026
Dexcom USD 2.08B 134.8M Jun/2026
Edwards Lifesciences USD 199.7M 10.8M Sep/2026
Eli Lilly USD 5.79B 319M Sep/2026
Globus Medical USD 107.43M 487K Sep/2026
ICU Medical USD 142.99M 6.18M Sep/2026
Inogen USD 21.22M 684K Sep/2025
Insulet USD 162.2M 38.9M Sep/2026
Integra LifeSciences USD 82.64M 5.31M Jun/2026
J&J USD 9.32B 94M Sep/2026
Medtronic USD 2.7B 51M Jun/2026
Merit Medical Systems USD 70.74M 2.88M Jun/2026
Roche Holding CHF 5.54B 237M Jun/2026
Solventum Corp USD 808M 107M Sep/2026
Stryker USD 1.66B 71M Jun/2026
Tandem Diabetes Care USD 74.8M 10.67M Sep/2026
Teleflex USD 142.87M 423K Sep/2026
West Pharmaceutical Services USD 249.4M 3.3M Sep/2026
Zimmer Biomet Holdings USD 357.5M 5.1M Sep/2026